Future Forward: Innovation at the Intersection

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.

Blue Moon Metals debuts on Nasdaq under 'BMM', appointing finance veteran Peter Madsen to its board to spearhead a major U.S. critical metals expansion.

Medical device maker Nuwellis appoints two new directors and sees three resign, a move tied directly to a critical upcoming $5 million equity investment.

Nuclear waste innovator Deep Isolation adds veteran Ralph Hunter to its board, signaling a major push to commercialize its deep borehole disposal technology.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.

Stockholders approve a $2.25/share cash deal with a Kemmons Wilson-led venture, marking a pivotal exit amid market consolidation and financial strain.

Andela's acquisition of assessment firm Woven tackles the AI talent gap with advanced, real-world tests, redefining how companies find elite engineers.

Facing a critical productivity gap, Québec launches a major initiative to boost its economy by championing homegrown technology adoption.

With a major $25 million financing, Rua Gold is set to accelerate exploration in NZ's rich gold districts, leveraging a new fast-track permit process.

A new 60-storey condo tower begins construction, set to deliver nearly 1,000 homes by 2030 and inject hundreds of millions into Toronto's economy.

As automakers enforce strict digital standards, DATAMYTE's new platform helps suppliers ditch spreadsheets for a connected, AI-driven quality system.

LiveWorld unveils a new AI roadmap for pharma, promising a safer, human-guided approach to tackle compliance and build trust in a high-risk industry.

Investors eye Great-West Lifeco's Q4 results on Feb. 11, anticipating if the financial giant can sustain its record-breaking momentum from Q3 2025.

Jabra's new Evolve3 headsets merge pro-grade audio and AI with a sleek, boomless design, aiming to be the one headset for both work and life.

With $35.1M in new funding, Infinitopes is launching a human trial for its AI-designed vaccine aimed at preventing oesophageal cancer recurrence.

Dental talent marketplace GoTu partners with SoFi to offer student loan refinancing and financial planning, addressing a key stressor for modern clinicians.

With an oversubscribed offering, Bravo Mining is set to accelerate its Luanga project, capitalizing on strong investor confidence and a bullish metals market.

PayPal users can now buy hundreds of digital gift cards and earn 5% cashback, a strategic move in the booming embedded finance and digital wallet market.

GSK's subsidiary Tesaro inks a deal worth up to $285M with Alteogen to create an under-the-skin version of its cancer drug Jemperli.

A landmark public-private partnership aims to transform Misurata's port into a top-tier trade hub, signaling a new economic era for post-conflict Libya.